Optics News

A pharmaceutical approach to presbyopia has clear advantages, will likely be used in combination with other approaches and may serve to drive surgical procedures.

Visual acuity loss and blindness rates within the U.S. vary depending on factors such as geographic location, age, sex or race and ethnicity, a study published in JAMA Ophthalmology revealed.

As a scleral lens fitter working in an ophthalmology group with cornea and cataract specialists, I try to hold off on sending a keratoconic patient for cataract surgery until it is absolutely necessary.

The International Myopia Institute announced that it released a set of white papers and yearly digest on myopia in a special edition of Investigative Ophthalmology and Visual Science.

The earlier we prepare patients for presbyopia — and reassure them that there are new treatment options on the horizon — the better.

WHO announced at the World Health Assembly on May 27 its target of increasing financial coverage of refractive error and cataract surgery by 2030 to combat blindness and vision impairment.

X-Cel announced the launch of its new contacts, REMLens, which feature a Rapid Eye Molding effect to combat myopic refractive errors overnight.

DENVER – Susan Gromacki, OD, presented a lecture at this year’s Optometry’s Meeting as an introductory course to starting a scleral lens practice and fitting procedures.

DENVER – Walt Whitley, OD, MBA, FAAO, presented an overview at this year’s Optometry’s Meeting on the current trends in presbyopia management, including available and upcoming technology and therapeutics.

DENVER – Orasis Pharmaceutical President and COO Paul Smith told Healio here at Optometry’s Meeting that the company is proceeding from positive phase 2 study results to enrollment for a phase 3 protocol.